Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05378763
Title A Study of Poziotinib in Previously Treated Participants With Locally Advanced or Metastatic NSCLC Harboring HER2 Exon 20 Mutations (PINNACLE)
Acronym PINNACLE
Recruitment Suspended
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Spectrum Pharmaceuticals, Inc
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST